Tiancheng Xu

机构：Nanjing University of Chinese Medicine · ORCID：0000-0001-7734-4256

发表论文 32 篇 · 总被引 852 次 · h-index 12

代表论文

• GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors (2022 · Cancer Research · 被引 86)
• Global, Regional, and National Burden of Valvular Heart Disease, 1990 to 2021 (2024 · Journal of the American Heart Association · 被引 70)
• Long-term performance and risk factors analysis after permanent His-bundle pacing and atrioventricular node ablation in patients with atrial fibrillation and heart failure (2020 · EP Europace · 被引 69)
• Electrophysiological characteristics and clinical values of left bundle branch current of injury in left bundle branch pacing (2020 · Journal of Cardiovascular Electrophysiology · 被引 68)
• Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma (2019 · British Journal of Cancer · 被引 62)
• Age shock index and age-modified shock index are strong predictors of outcomes in ST-segment elevation myocardial infarction patients undergoing emergency percutaneous coronary intervention (2019 · Coronary Artery Disease · 被引 35)